首页 | 本学科首页   官方微博 | 高级检索  
检索        

黄芪甲苷在体外对高迁移率族蛋白B1介导小鼠调节性T淋巴细胞免疫功能的影响
引用本文:李金凤,;黄立锋,;姚咏明,;张淑文,;李文雄,;张震宇,;王淑珍.黄芪甲苷在体外对高迁移率族蛋白B1介导小鼠调节性T淋巴细胞免疫功能的影响[J].北京中医药,2014(11):852-856.
作者姓名:李金凤  ;黄立锋  ;姚咏明  ;张淑文  ;李文雄  ;张震宇  ;王淑珍
作者单位:[1]首都医科大学附属北京朝阳医院妇产科,北京100020; [2]首都医科大学附属北京朝阳医院SICU,北京100020; [3]解放军总医院第一附属医院全军烧伤研究所,北京100048; [4]首都医科大学附属北京友谊医院感染暨急救医学科,北京1000SO
基金项目:国家自然科学基金资助项目(81372042,81341056,30901561); 北京市“科技新星计划”资助项目(Z141107001814043)
摘    要:目的在前期实验基础上,明确经高迁移率族蛋白B1(HMGB1)刺激的小鼠调节性T细胞(Treg)对CD4^+CD25^-T淋巴细胞免疫功能的影响,观察黄芪甲苷(AST IV)对HMGB1介导Treg免疫功能的拮抗作用。方法随机将CD4^+CD25^-T细胞分为对照组、Treg组、(HMGB1+Treg)组、(HMGB1+AST IV+Treg)组。4组均于培养后72 h检测脾脏CD4^+CD25^-T细胞增殖活性及CD4^+CD25^-T细胞孵育上清液中IL-4、IFN-γ表达水平。结果 Treg组CD4^+CD25-T细胞增殖活性受到抑制(P〈0.01),其上清中IFN-γ表达水平较对照组明显下降(P〈0.01),IL-4表达水平较对照组显著增加(P〈0.01);HMGBI+Treg组CD4^+CD25-T细胞增殖活性受抑制程度明显逆转(P〈0.01),与Treg组比较,(HMGB1+Treg)组IFN-γ表达水平明显升高(P〈0.01),IL-4表达水平显著下降(P〈0.01);与(HMGB1+Treg)组比较,(HMGB1+AST IV+Treg)组CD4^+CD25^-T细胞增殖受抑制程度显著加重(P〈0.01),IFN-γ表达水平明显降低(P〈0.01),IL-4水平显著上升(P〈0.01)。结论 HMGB1在体外可明显降低小鼠Treg免疫抑制能力,而黄芪甲苷可拮抗此抑制作用,表明其对HMGB1介导的促炎效应具有治疗作用。

关 键 词:高迁移率族蛋白B1  调节性T细胞  黄芪甲苷  免疫抑制  脓毒症

Effects of astragaloside IV on immune function of regulatory T cell in mice mediated by high-mobility group protein B1 in vitro
Institution:LI Jin-feng , HUANG Li-feng, YAO Yong-ming, ZHANG Shu-wen, LI Wen-xiong, ZHANG Zhen-yu, WANG Shu-zhen (1. Department of Obstetrics and Gynecology, Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing 100020, China; 2. Department of Surgical Intensive Care Unit, Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing 100020; 3. PLA Burns Institute, The First Affiliated Hospital of Chinese PLA General Hospital, Beijing 100048 ; 4. Department of Infectious Diseases and Critical Care Medicine, Beijing Friendship Hospital affiliated to Capital Medical University, Beijing 100050 )
Abstract:Objective Based previous studies to explore the effects of mice regulatory T cell( Treg) stimulated by high-mobility group protein B1( HMGB1) on immune function of CD4^+CD25^-T cells,and to observe the antagonistic effects of astragaloside IV( AST IV)on immune function of Treg mediated by HMGB1. Methods CD4^+CD25^-T cells were randomly divided into a control group,a Treg group,a( HMGB1 + Treg) group and a( HMGB1 + AST IV + Treg) group. 72 h after cell culture,CD4^+CD25^-T cells and the liquid supernatant were again collected to measure the proliferative activity of CD4^+CD25^-T cells and expression level of IL-4 and IFN-γ in the liquid supernatant in spleen in four groups. Results The proliferative activity of CD4^+CD25^-T cells was inhibited in the Treg group( P〈0. 01),and the expression level of IFN-γ was significantly increased compared with that in the control group( P〈0. 01). When Treg that was stimulated with HMGB1 was added in the( HMGB1 + Treg) group,the inhibited proliferative activity of CD4^+CD25^-T cells was significantly reversed( P〈0. 01),compared with the Treg group,the expression level of IFN-γ in the HMGB1 + Treg group was obviously increased and that of IL-4 was evidently reduced( P〈0. 01). Compared with( HMGB1 + Treg) group,the degree of inhibited proliferative activity of CD4^+CD25^-T cells was enhanced( P〈0. 01),the expression level of IFN-γ was obviously reduced and that of IL-4 was evidently increased( P〈0. 01). Conclusion HMGB1 in vitro could obviously reduce Treg immunosuppression in mice,and astragaloside IV have an antagonism effect, indicating its therapeutic effect on pro-inflammatory effects meditated byHMGB1.
Keywords:high mobility group box-1 protein  regulatory T cell  astragaloside IV  Immune suppression  sepsis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号